Relitigating Aduhelm: CDER’s Cavazzoni Uses Leqembi Approval To Defend Aducanumab Decision

 
• By Sue Sutter
Shield and sword
CDER defended Aduhelm's approval in its announcement of Leqembi's licensure. • Source: Shutterstock

More from Approvals

More from Product Reviews